MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Esperion Therapeutics (ESPR) Ownership - Who owns Esperion Therapeutics?
Esperion Therapeutics Inc is a pharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
572.61M
P/E Ratio
N/A
Total Cash
86.06M
Projected Growth
N/A
Total Debt
302.27M
Revenue
268.13M
Risk (Beta)
3.01
Dividend Yield
N/A
Total Cash/Share
0.43
Total Debt/Equity
N/A
Revenue/Share
1.37 USD as % of share price
Fundamentals
ESPR
Capitalization
573M
P/E Ratio
N/A
Risk (Beta)
3.01
Dividend Yield
N/A
Total Cash
86.1M
Total Cash/Share
0.43
Total Debt
302M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.37%
Revenue
268M
ROE
N/A
Book Value
-433.51M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
200K
Current Ratio
1.15
Current Revenue Per Employee
271003.28
Dividends Per Share - Security
N/A
EBITDA
-32.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.35
Revenue To Assets
-29.75
Shares Held By Institutions
192M
Shares Outstanding - Current
202M
Total Liabilities
781M
Total Volume MTD
N/A
Value
N/A
Gain YTD
29.091
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ESPR showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com